Innovation Theater (non-accredited) - Adjuvant Treatment with LIBTAYO for Patients with Cutaneous Squamous Cell Carcinoma (CSCC) at High Risk of Recurrence After Surgery and Radiation

Name: Innovation Theater (non-accredited) - Adjuvant Treatment with LIBTAYO for Patients with Cutaneous Squamous Cell Carcinoma (CSCC) at High Risk of Recurrence After Surgery and Radiation
Start: 2026-04-11T07:45:00-04:00
End: 2026-04-11T08:30:00-04:00
Location: Virtual Series

Innovation Theater

Innovation Theater (non-accredited) - Adjuvant Treatment with LIBTAYO for Patients with Cutaneous Squamous Cell Carcinoma (CSCC) at High Risk of Recurrence After Surgery and Radiation

45 min

Saturday, April 11, 2026

7:45 AM - 8:30 AM

Sponsored by Regeneron Pharmaceuticals, Inc.